Press release
Global Molecular Oncology Diagnostics Market to Surpass $6.19 Billion by 2033, Driven by Precision Medicine

The global molecular oncology diagnostics market is experiencing strong growth. With 2023 as the base year, the market size is estimated at $2,410.9 million in 2024 and is projected to reach $6,195.1 million by 2033, registering a CAGR of 11.06% during th
BIS Research, a leading provider of market intelligence on transformative technologies, announces the release of its latest comprehensive study, "Global Molecular Oncology Diagnostics Market [https://bisresearch.com/industry-report/molecular-oncology-diagnostics-market.html?utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr] - Analysis and Forecast, 2024-2033."According to the report, the global molecular oncology diagnostics market was valued at $2,410.9 million in 2024 and is projected to reach $6,195.1 million by 2033, growing at a CAGR of 11.06% during the forecast period.
The report highlights how a paradigm shift in cancer management-driven by precision medicine, genomics research, and noninvasive testing methods-is unlocking tremendous growth opportunities for stakeholders across the healthcare ecosystem.
Precision Medicine: A Catalyst for Market Growth
Cancer remains one of the leading causes of morbidity and mortality worldwide, prompting healthcare systems to adopt innovative approaches for early detection, monitoring, and treatment. Molecular oncology diagnostics has emerged as a critical enabler of precision medicine-the practice of tailoring treatments based on the molecular profile of each patient's tumor.
Technologies such as nextgeneration sequencing (NGS), polymerase chain reaction (PCR), and in situ hybridization are now standard tools for identifying mutations, guiding targeted therapies, and improving patient outcomes. This personalized approach is fueling demand for robust diagnostic platforms capable of delivering accurate, fast, and actionable results.
Request a Sample [https://bisresearch.com/requestsample?id=2707&type=download&utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr] for Molecular Oncology Diagnostics Market - A Global and Regional Analysis 2024-2034
Key Trends Driving the Market
1. Liquid Biopsy Adoption Liquid biopsy is transforming how cancers are detected and monitored. By analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples, clinicians can detect minimal residual disease (MRD), monitor treatment response, and identify emerging resistance-all without invasive tissue biopsies.
2. Companion Diagnostics Growth Pharmaceutical companies are increasingly pairing targeted therapies with companion diagnostics. This codevelopment model ensures therapies are administered to patients most likely to benefit, improving clinical outcomes and optimizing costs.
3. Technological Innovations Advancements in NGS platforms, multiplex panels, and bioinformatics are expanding the scope of molecular diagnostics, enabling the analysis of multiple genes simultaneously and generating comprehensive molecular profiles.
4. Global Focus on Early Detection Governments and healthcare organizations worldwide are investing in cancer screening programs, which is boosting adoption of advanced molecular tests for early intervention.
Market Segmentation and Opportunities
The BIS Research report segments the market by technology, application, cancer type, end user, and region, offering granular insights for industry stakeholders.
*
By Technology: NGS is projected to lead growth due to its scalability and declining costs. PCR remains vital for routine applications, while fluorescence in situ hybridization (FISH) and microarrays maintain niche roles.
*
By Application: Diagnostics for lung cancer, breast cancer, colorectal cancer, and hematological malignancies remain dominant, with expanding opportunities in rare cancers.
*
By End User: Hospitals and reference laboratories currently account for the largest share, while oncology centers and research institutes are witnessing increased adoption.
Regional Insights
*
North America remains the market leader, supported by strong R&D investments, rapid regulatory approvals, and a mature healthcare infrastructure.
*
Europe is witnessing significant growth driven by stringent diagnostic standards and high awareness of precision medicine.
*
AsiaPacific is expected to register the fastest CAGR due to rising cancer prevalence, expanding healthcare access, and governmentbacked genomics initiatives.
Visit Here for Access Of TOC [https://bisresearch.com/requestsample?id=2707&type=toc]
Implications for Stakeholders
The market's trajectory offers opportunities for a wide spectrum of stakeholders:
*
Diagnostic Manufacturers: Accelerate innovation in NGS and liquid biopsy platforms.
*
Pharmaceutical Companies: Expand companion diagnostic partnerships to enhance targeted therapy pipelines.
*
Healthcare Providers: Integrate molecular testing into clinical workflows to improve patient outcomes.
*
Investors and Consultants: Identify highgrowth segments and emerging players in a dynamic market.
About BIS Research
BIS Research, recognized as a top market research company, specializes in market research reports and advisory services focused on deep technology and emerging trends that are poised to disrupt key industrial markets. Annually, we publish over 200 market intelligence reports across various deep technology verticals.
Our insights support leaders across industries in making informed decisions based on deep market analysis, competitive intelligence, and strategic forecasting. We work closely with innovation-driven stakeholders across data centers, energy & Power, healthcare, and more. We help businesses stay ahead with in-depth reports, custom research [https://bisresearch.com/our-offerings/custom-research?utm_source=Monika&utm_medium=Organic&utm_campaign=abnewswire-pr], and go-to-market strategies [https://info.bisresearch.com/market-entry-strategy?utm_source=Monika&utm_medium=Organic&utm_campaign=abnewswire-pr] tailored to your goals.
Media Contact
Company Name: BIS Research
Contact Person: Bhavya Banga
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-molecular-oncology-diagnostics-market-to-surpass-619-billion-by-2033-driven-by-precision-medicine]
Phone: +1-510-404-8135
Address:39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538
Country: United States
Website: https://bisresearch.com/industry-report/molecular-oncology-diagnostics-market.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Molecular Oncology Diagnostics Market to Surpass $6.19 Billion by 2033, Driven by Precision Medicine here
News-ID: 4108722 • Views: …
More Releases from ABNewswire

Europe Garage Door Market Volume to Surge to 2.36 Million Units by 2030 as EU Ho …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
According to Arizton latest research report, Europe garage door market [https://www.arizton.com/market-reports/europe-garage-doors-market]is growing at a CAGR of 3.10% during 2024-2030.
Looking for More Information? Click: https://www.arizton.com/market-reports/europe-garage-doors-market
Report Scope:
MARKET SIZE - REVENUE (2030): USD 3.20 Billion
MARKET SIZE - REVENUE (2024): USD 2.66 Billion
CAGR - REVENUE (2024-2030): 3.10%
MARKET SIZE - VOLUME (2030): 2.36 Million Units
HISTORIC YEAR: 2021-2023
BASE YEAR: 2024
FORECAST YEAR: 2025-2030
MARKET…

Influenza Pipeline Outlook 2025 - Clinical Trials, Treatment, ROA, Medication, M …
The Influenza pipeline is experiencing unprecedented growth, driven by 120+ active players, breakthrough therapies, and recent FDA fast-track designations, signaling a transformative decade ahead in Influenza treatment.
Influenza Pipeline Summary
DelveInsight's Influenza Emerging Drugs report highlights innovative therapies advancing the treatment and prevention of influenza. Key candidates include Moderna's mRNA-1010, a Phase III vaccine encoding HA glycoproteins of WHO-recommended strains; SAB Biotherapeutics' SAB-176, a quadrivalent, broadly neutralizing polyclonal antibody for severe influenza;…

Chronic Refractory Cough Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDM …
DelveInsight's, "Chronic Refractory Cough Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Chronic Refractory Cough pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

PCSK9 Inhibitors Market Landscape: Clinical Pipeline, Competitive Strategies, an …
DelveInsight's PCSK9 Inhibitors Market Report highlights strong growth potential, with the 7MM market projected to expand significantly by 2034 from USD 2B in 2023. The U.S. leads with ~USD 900M. Key players include Sanofi, Regeneron, Amgen, AstraZeneca, LIB Therapeutics, Merck, Novartis, Alnylam, Aqur Biosciences, and CiVi Biopharma. Current leaders PRALUENT and REPATHA dominate, while pipeline assets like LIB003 and MK-0616 signal the next wave of innovation.
DelveInsight's comprehensive [https://www.delveinsight.com/report-store/pcsk9-inhibitors-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report, provides…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
[CAGR of 5.5%] Silica Flour Market Size, CAGR, Competitive Analysis and Forecast …
The global silica flour industry generated $520.0 million in 2021, and is estimated to reach $876.3 million by 2031, witnessing a CAGR of 5.5% from 2022 to 2031.
Allied Market Research published a report, titled, "Silica Flour Market by Type (Quartz, Cristobalite), by Application (Fiberglass, Glass and Clay, Oil Well Cement, Ceramic and Refractory, Foundry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." The report offers a detailed analysis…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Call Center AI Market Latest, CAGR, Volume and Value 2022-2030 | (CAGR) of 25%
New York , United States- Report Ocean published the latest research report on the Call Center AI market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Call Center AI market study demonstrates a detailed examination of the business state, which represents creative ways for company growth,…